Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 28
Filtrar
1.
Eur Rev Med Pharmacol Sci ; 13(4): 285-93, 2009.
Artículo en Inglés | MEDLINE | ID: mdl-19694343

RESUMEN

BACKGROUND: During intestinal inflammation white blood cells are recruited from the blood, and they represent the major contributors to tissue perpetuation of inflammation via their production of chemokines and proinflammatory cytokines. OBJECTIVES: Investigate the effect of a symbiotic formulation containing Lactobacillus Paracasei B 20160 versus placebo, on serum levels of interleukin (IL)-6, tumor necrosis factor (TNF)alpha, IL-8, IL-1beta and IL-10 and on mRNA lymphomonocyte expression of TNFalpha, IL-8 and IL-1beta in patients with ulcerative colitis. MATERIALS AND METHODS: Eighteen patients entered the study with histologically proven not complicated ulcerative colitis, treated with mesalazine. Patients were treated for 8 weeks (9 with symbiotic and 9 with placebo). Serum levels of IL-6, TNFalpha, IL-8, IL-1beta and IL-10 were measured using a commercially available sandwich ELISA kit. RT-PCR analysis was performed on total RNA isolated from peripheral lymphomonocytes. RESULTS: In basal condition, there was an increase of serum levels of TNFalpha, IL-6, and IL-8. The treatment with symbiotic significantly decreased serum levels of the last two cytokines (IL-6 and IL-8). In lymphocytes, the treatment with the symbiotic don't significantly reduced the mRNA expression of TNFalpha and IL-1beta, while that of IL-8 was strongly and significantly decreased. CONCLUSION: Our preliminary results suggest that a symbiotic formulation containing Lactobacillus paracasei significantly improves the plasma and lymphocyte content of some proinflammatory cytokines.


Asunto(s)
Colitis Ulcerosa/terapia , Citocinas/metabolismo , Regulación de la Expresión Génica , Lactobacillus , Adulto , Anciano , Antiinflamatorios no Esteroideos/uso terapéutico , Colitis Ulcerosa/inmunología , Citocinas/sangre , Ensayo de Inmunoadsorción Enzimática , Femenino , Humanos , Interleucinas/sangre , Interleucinas/metabolismo , Leucocitos Mononucleares/inmunología , Leucocitos Mononucleares/metabolismo , Masculino , Mesalamina/uso terapéutico , Persona de Mediana Edad , Proyectos Piloto , ARN Mensajero/metabolismo , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa , Factor de Necrosis Tumoral alfa/sangre , Factor de Necrosis Tumoral alfa/metabolismo , Adulto Joven
2.
Dig Liver Dis ; 37(8): 593-600, 2005 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-15869912

RESUMEN

BACKGROUND: Previous studies reported an impairment of both the physical and mental dimensions of quality of life in patients with cirrhosis. Very few data are available on the psychological impact of the disease and its relation to liver function. AIM: To measure the psychological status of patients with cirrhosis in relation to the severity of the liver impairment. PATIENTS AND METHODS: One hundred and fifty-six patients with cirrhosis were studied. Two questionnaires (the Beck Depression Inventory and the Psychological General Well-Being Index) were self-administered in random order. Clinical and laboratory data were collected using standardised forms. RESULTS: The global score of Psychological General Well-Being Index was severely reduced compared to Italian population norm. Among individual domains, the more severely affected was General Health, the less compromised was Positive Well-Being. A negative relation was found between Child-Pugh score (a comprehensive measure of disease severity) and global Psychological General Well-Being Index and several individual subscales. The Beck Depression Inventory scores were indicative of a depressed mood in over 50% of patients, in relation to the presence of clinical symptoms. CONCLUSIONS: Patients with cirrhosis have signs of psychological distress and depression, as assessed by Beck Depression Inventory and Psychological General Well-Being Index, in relation to the severity of liver disease. Accordingly, a non-negligible number of patients warrant treatment.


Asunto(s)
Depresión/diagnóstico , Cirrosis Hepática/psicología , Estrés Psicológico/diagnóstico , Adulto , Anciano , Anciano de 80 o más Años , Consumo de Bebidas Alcohólicas/psicología , Femenino , Humanos , Modelos Logísticos , Masculino , Persona de Mediana Edad , Estudios Prospectivos , Escalas de Valoración Psiquiátrica , Calidad de Vida , Índice de Severidad de la Enfermedad , Trastornos del Sueño-Vigilia/psicología , Encuestas y Cuestionarios
3.
Dig Liver Dis ; 35(1): 46-54, 2003 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-12725608

RESUMEN

BACKGROUND: It has been shown that health-related quality of life is reduced in patients with cirrhosis and with chronic hepatitis in relation to antiviral therapy. No data are available on patients with hepatocellular carcinoma. AIM: To assess health-related quality of life in cirrhotic patients with hepatocellular carcinoma. PATIENTS AND METHODS: Health-related quality of life was assessed in 101 hepatocellular carcinoma patients by means of Short Form-36 and Nottingham Health Profile questionnaires. Final scores of domains for individual patients were compared to age-adjusted normative Italian values, using Z-score and with values obtained in 202 matched patients with cirrhosis, without hepatocellular carcinoma. RESULTS: All Short Form-36 domains and 4 out of 6 Nottingham Health Profile domains were altered. When hepatocellular carcinoma patients were compared with matched cirrhotics, differences were present for Bodily Pain, Role Limitation-Physical, and the Physical Component Summary of Short Form-36, as well as Pain of Nottingham Health Profile. Perceived health status had changed significantly in the year prior to assessment. Health-related quality of life was not primarily related to tumour mass or hepatocellular failure, whereas sleep disorders were selected by logistic regression as strongly associated with poor health-related quality of life. CONCLUSIONS: The present data stress the relevance of pain in poor perceived health status of hepatocellular carcinoma patients, and the importance of minor symptoms, such as sleep disorders.


Asunto(s)
Carcinoma Hepatocelular , Indicadores de Salud , Neoplasias Hepáticas , Calidad de Vida , Adulto , Anciano , Anciano de 80 o más Años , Carcinoma Hepatocelular/complicaciones , Estudios Transversales , Femenino , Humanos , Cirrosis Hepática/complicaciones , Neoplasias Hepáticas/complicaciones , Modelos Logísticos , Masculino , Persona de Mediana Edad
4.
Gastroenterology ; 120(1): 170-8, 2001 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-11208726

RESUMEN

BACKGROUND & AIMS: Increasing interest is being given to health-related quality of life in chronic diseases. In cirrhosis, both physical functioning and mental well-being may be altered, but no study has investigated factors associated with a poor perceived health status. METHODS: We measured quality of life by Short Form-36 and Nottingham Health Profile questionnaires in 544 patients with cirrhosis. Data were compared with age- and gender-adjusted values of 2 random samples of the Italian population (more than 2000 subjects). Factors associated with poor perceived health status were identified by logistic regression. RESULTS: All domains of health-related quality of life, except pain, were altered in cirrhosis (by 9%-42%), mainly in younger patients. There were minor differences in relation to gender, whereas etiology had no effects. Severity of disease (Child-Pugh score) and, above all, muscle cramps were the factors most closely associated with poor health status perception. Self-rating of disease progression was associated with ascites and pruritus, whereas previous variceal sclerotherapy and the use of disaccharides had a protective effect. Most areas of daily life were affected by perceived health problems; this was mainly true for paid employment and sex life in men and home life and social life in women. CONCLUSIONS: Quality of life is variably impaired in cirrhosis, also in uncomplicated patients. Non-life-threatening symptoms, such as muscle cramps, are of major concern. These data are the basis for longitudinal studies measuring the effects of therapy and procedures on patient-derived health outcomes.


Asunto(s)
Cirrosis Hepática/psicología , Calidad de Vida , Anciano , Femenino , Estado de Salud , Humanos , Masculino , Persona de Mediana Edad , Calambre Muscular/psicología , Prurito/psicología , Encuestas y Cuestionarios
5.
Gut ; 48(1): 28-33, 2001 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-11115819

RESUMEN

BACKGROUND: 5-Fluorouracil (FU) in association with folinic acid (FA) is the most frequently used chemotherapeutic agent in colorectal cancer but it often causes diarrhoea. Animal and human studies suggest that glutamine stimulates intestinal mucosal growth. AIM: To determine if oral glutamine prevents changes in intestinal absorption (IA) and permeability (IP) induced by FU/FA. METHODS: Seventy chemotherapy naive patients with colorectal cancer were randomly assigned to oral glutamine (18 g/day) or placebo before the first cycle of FU (450 mg/m(2)) and FA (100 mg/m(2)) administered intravenously for five days. Treatment was continued for 15 days, starting five days before the beginning of chemotherapy. IA (D-xylose urinary excretion) and IP (cellobiose-mannitol test) were assessed at baseline and four and five days after the end of the first cycle of chemotherapy, respectively. Patients kept a daily record of diarrhoea, scored using the classification system of the National Cancer Institute (Bethesda, Maryland, USA). Duration of diarrhoea was recorded and the area under the curve (AUC) was calculated for each patient. RESULTS: Baseline patient characteristics and basal values of IP and IA tests were similar in the two arms. After one cycle of chemotherapy, the reduction in IA (D-xylose absorption) was more marked in the placebo arm (7.1% v 3. 8%; p=0.02); reduction of IP to mannitol was higher in the placebo arm (9.2% v 4.5%; p=0.02); and urinary recovery of cellobiose was not different between the study arms (p=0.60). Accordingly, the cellobiose-mannitol ratio increased more in the placebo arm (0.037 v 0.012; p=0.04). Average AUC of diarrhoea (1.9 v 4.5; p=0.09) and average number of loperamide tablets taken (0.4 v 2.6; p=0.002) were reduced in the glutamine arm. CONCLUSIONS: Glutamine reduces changes in IA and IP induced by FU and may have a protective effect on FU induced diarrhoea.


Asunto(s)
Antimetabolitos Antineoplásicos/efectos adversos , Diarrea/prevención & control , Fluorouracilo/efectos adversos , Glutamina/administración & dosificación , Administración Oral , Adulto , Anciano , Neoplasias del Colon/complicaciones , Neoplasias del Colon/tratamiento farmacológico , Diarrea/inducido químicamente , Método Doble Ciego , Femenino , Humanos , Absorción Intestinal/efectos de los fármacos , Masculino , Persona de Mediana Edad , Estadísticas no Paramétricas
6.
J Med Screen ; 7(3): 160-2, 2000.
Artículo en Inglés | MEDLINE | ID: mdl-11126166

RESUMEN

OBJECTIVES: The main objective of the study was to evaluate if speculoscopy, a magnified chemiluminescent examination, combined with a Pap smear, could improve the detection of early cervical lesions compared with the Pap smear alone. SETTING: Pap tests and speculoscopies were performed in two family planning centres located in the surrounding areas of Modena. Colposcopic investigations and biopsies of the uterine cervix were performed in a second level centre (Gynaecological Prevention Centre of Modena Policlinico). Histological specimens were analysed at the Section of Pathological Anatomy of Modena Policlinico. SUBJECTS: The study population comprised 1000 women aged 25-64 years, invited to undergo a Pap smear every three years in accordance with the screening programme for cervical cancer started in Modena in 1997. METHODS: Midwives performed the Pap smear and speculoscopy in succession. Women with a positive Pap test and/or positive speculoscopy underwent colposcopy and, if colposcopic findings were positive, targeted punch biopsies were performed. RESULTS: A total of 1000 patients were subjected to cytology and speculoscopy examinations. Among these women, 10 had abnormal Pap smear findings whereas 144 had an abnormal speculoscopic pattern. Only three of 59 patients with a histological diagnosis of cervical intraepithelial neoplasia grade I (CIN I)/human papillomavirus and only three of seven patients with CIN II/CIN III had a positive Pap test. CONCLUSIONS: Speculoscopy combined with a Pap test can significantly increase the detection of cervical lesions when included in a screening programme.


Asunto(s)
Tamizaje Masivo/organización & administración , Prueba de Papanicolaou , Neoplasias del Cuello Uterino/epidemiología , Neoplasias del Cuello Uterino/patología , Frotis Vaginal/estadística & datos numéricos , Adulto , Biopsia , Colposcopía , Femenino , Humanos , Incidencia , Italia/epidemiología , Tamizaje Masivo/estadística & datos numéricos , Persona de Mediana Edad , Partería , Frotis Vaginal/métodos , Displasia del Cuello del Útero/epidemiología , Displasia del Cuello del Útero/patología
7.
Dig Liver Dis ; 32(5): 398-405, 2000.
Artículo en Inglés | MEDLINE | ID: mdl-11030185

RESUMEN

BACKGROUND: Quality of life is an area of increasing interest in hepatology. Studies, so far, have assessed quality of life in patients with chronic virus C-related hepatitis in relation to antiviral therapy by means of generic questionnaires. AIM: To measure quality of life in chronic hepatitis patients without cirrhosis by means of the Nottingham Health Profile questionnaire, a measure of "distress" in comparison with the Medical Outcome Survey SF-36, an index of well-being. PATIENTS: A series of 126 outpatients with chronic hepatitis; 37 on and 89 not on active interferon treatment. METHODS: The two questionnaires were used in random order. Clinical and laboratory data were also collected. The final score of any domain of the two questionnaires, for any individual patient, was compared to age-adjusted normal values obtained in 2 random samples of Italian population. RESULTS: Patients showed a significant modification of 3 domains of Nottingham Health Profile (Energy, Social Isolation and Physical Mobility) and 6 domains of SF-36. In relation to interferon treatment, the Nottingham Health Profile questionnaire was able to detect differences in Energy, Physical Mobility and Pain, which were modified only in treated patients. SF-36 did not show any differences in relation to treatment. In addition, the Nottingham Health Profile demonstrated that treated patients had a lower prevalence of concern for family life, possibly due to expectations of treatment itself. CONCLUSIONS: Active interferon treatment causes considerable distress in chronic hepatitis C patients, adding to the perceived change in health status caused by liver disease.


Asunto(s)
Hepatitis C Crónica/psicología , Hepatitis C Crónica/terapia , Interferones/uso terapéutico , Calidad de Vida , Adulto , Anciano , Femenino , Humanos , Masculino , Persona de Mediana Edad , Encuestas y Cuestionarios
8.
J Low Genit Tract Dis ; 4(4): 212-6, 2000 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-25951158

RESUMEN

OBJECTIVE: This study evaluates the performance of Papanicolaou smear combined with speculoscopy in improving the predictive value of minor grade cervical cytological abnormalities. MATERIALS AND METHODS: A total of 3,300 asymptomatic women who had routine cervical smears were studied in 32 Italian centers. All these women underwent Pap smear and speculoscopy. The women positive at Pap smear or speculoscopy (n = 908) were referred for colposcopy and directed punch biopsy/endocervical curettage was performed when appropriate. RESULTS: Of the 908 patients referred for colposcopy, 538 underwent biopsy; 92 of these had a cervical lesion (cervical intraepithelial neoplasia [CIN]) confirmed on histology (67 CIN1 and 25 CIN2-3). Speculoscopy pointed out an area to biopsy in 84% of the CIN1 and in 75% of the CIN2-3 cases among women who showed minor (low-grade squamous intraepithelial lesion or less) cytological abnormalities. CONCLUSIONS: The potential combination of cytology and speculoscopy as an intermediate test in patients with minor grade cytologic (atypical squamous cells of undetermined significance or low-grade squamous intraepithelial lesion) cervical changes may decrease the number of recalls and directed biopsies in a cost-effective manner.

9.
Radiol Med ; 100(4): 273-8, 2000 Oct.
Artículo en Italiano | MEDLINE | ID: mdl-11155455

RESUMEN

PURPOSE: This prospective, non-randomized study was aimed at evaluating the incidence of Delayed Adverse Drug Reactions (DADRs) to iodinated contrast agents and to evaluate possible risk factors to the development of these reactions. DADRs are those reactions occurring one to 48 hours after contrast medium administration. Their symptoms and frequency are not well defined, but the majority of DADRs are mild in intensity and resolve spontaneously without sequelae. In the literature, DADRs are reported to occur in 1 to 15% of patients undergoing contrast-enhanced examinations. MATERIAL AND METHODS: This prospective, non-randomized trial was carried out on 403 patients undergoing either dynamic CT or urography with iopamidol-300 (Iopamiro-300, Bracco SpA). Before the examination, data were collected regarding patients' anagraphical details, presence of risk factors, allergy, previous exposure and previous adverse reactions to iodinated contrast agent. After the examination, any adverse events occurring between 30 minutes and 48 hours post-dose were recorded, specifying time of onset and duration of symptoms. Studied variables were type of DADRs and risk factors to their development (sex, age, underlying disease, allergy, previous exposure to contrast agent, type of diagnostic examination). Two hundred and sixty-two patients were male (65%), and 141 were female (35%). Mean age was 61 years (+/- 11.8); 192 patients (48%) had underlying disease, and 115 (28%) were allergic. About half of the patients had previously undergone another contrast-enhanced examination. Two hundred and seventy-one patients underwent dynamic CT and 132 urography. RESULTS: A total of 50 patients (12.4%) reported DADRs. Factors associated with a significantly higher incidence of DADRs were found to be allergy (p = 0.001), previous exposure to contrast agent (p = 0.001), female sex (p = 0.001), underlying disease (p = 0.030). The most frequently reported DADRs were nausea and vomiting, drowsiness, rash, itching and headache. All reported reactions were mild and resolved spontaneously without sequelae. DISCUSSION AND CONCLUSIONS: In our experience, though limited and not on large numbers, DADRs to nonionic low osmolality contrast agents such as iopamidol have been few, mild, and not clinically significant. Although there are no absolute contraindications to the use of iodinated contrast agent, the risk/benefit ratio should always be evaluated, especially in patients with allergy, in those with severe renal, hepatic or cardiac insufficiency, and in diabetics.


Asunto(s)
Medios de Contraste/efectos adversos , Hipersensibilidad a las Drogas/etiología , Yopamidol/efectos adversos , Adulto , Distribución por Edad , Anciano , Femenino , Humanos , Masculino , Persona de Mediana Edad , Estudios Prospectivos , Distribución por Sexo , Tomografía Computarizada por Rayos X , Urografía
10.
Eur J Cancer Prev ; 7(4): 295-304, 1998 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-9806118

RESUMEN

The present study evaluates whether speculoscopy, a magnified chemiluminescence examination, combined with Pap smear can improve the detection of cervical lesions, as compared with Pap smear alone. The investigation was a prospective practice-based research carried out as a multicentre cohort study throughout the Italian territory. The participants were 3,300 asymptomatic women age > or = 18 years undergoing routine pelvic and cytological screening. All participants were subjected to Pap smear, speculoscopy and colposcopy investigations in succession. The 646 women with positive colposcopy underwent biopsy. Of the 267 women with positive histology 25 were high-grade intraephitelial lesions (HGSIL) and 242 were low-grade intraephitelial lesions (LGSIL). The histological findings were correlated with the results of Pap smear and speculoscopy alone and combined (PPS). Pap smear alone detected 76% of HGSIL, speculoscopy alone identified 84% of HGSIL, and PPS indicated 100% HGSIL. Of the 242 women with LGSIL, Pap smear alone detected 37% of the cases, speculoscopy alone detected 54% of the cases, and PPS identified 91% of the cases. Together, the two tests missed 9% of the LGSIL. The combination PPS was found to increase sensitivity from 40% to 92%, but to lower specificity from 94% to 23%. Speculoscopy combined with Pap smear can yield a higher percentage of women with biopsy-confirmed cervical pathology than the use of Pap smear as a sole screening test. This is particularly true of patients with LGSIL. The mechanisms of pathological detection and the use of speculoscopy should be investigated further.


Asunto(s)
Prueba de Papanicolaou , Neoplasias del Cuello Uterino/diagnóstico , Frotis Vaginal/métodos , Adolescente , Adulto , Femenino , Humanos , Mediciones Luminiscentes , Tamizaje Masivo/métodos , Persona de Mediana Edad , Sensibilidad y Especificidad , Neoplasias del Cuello Uterino/prevención & control
11.
Dig Dis Sci ; 43(8): 1752-4, 1998 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-9724164

RESUMEN

Glutamine represents the principal metabolic substrate for all rapidly proliferating cells. Since part of the glutamine efficacy could be related to immunoregulating properties, we assessed the effects of orally administered glutamine on serum interleukin-2 (IL-2) levels and intestinal T-cell populations in 48 athymic (nude) mice. Twenty-four mice received a standard diet enriched by glutamine (added to drinking water at a 4% concentration), while the other 24 served as the control group and received the same diet without glutamine. In glutamine-fed animals, we observed a marked increase in IL-2 concentrations after 10 days of treatment in comparison with control group and a modest but significant increase in intestinal T-cell counts. These results suggest that oral glutamine is able to exert local and systemic immunostimulating activity that could be of relevance in the prevention of gut integrity and immune defense loss associated, for example, with trauma, surgery, and starvation.


Asunto(s)
Adyuvantes Inmunológicos/administración & dosificación , Glutamina/administración & dosificación , Interleucina-2/sangre , Mucosa Intestinal/inmunología , Linfocitos T/inmunología , Adyuvantes Inmunológicos/farmacología , Administración Oral , Animales , Femenino , Glutamina/farmacología , Mucosa Intestinal/citología , Ratones , Ratones Desnudos , Subgrupos de Linfocitos T
12.
J Hepatol ; 23(1): 39-46, 1995 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-8530808

RESUMEN

In 40 patients with cirrhosis on a dietary protein regimen of 1 g/kg b.w., we determined the effect on chronic hepatic encephalopathy of long-term administration of Enterococcus faecium (SF68) versus lactulose. The patients received one of the two treatments for three periods of 4 weeks, each separated by drug-free 2-week intervals. The efficacy of treatment was assessed by arterial blood ammonia concentration, mental status, number connection (Reitan's part A) test and flash-evoked visual potentials. At the end of the third period the reduction in both blood ammonia concentrations and Reitan's test times was more enhanced in patients on SF68 than in patients on lactulose. Furthermore, while patients on lactulose tended to return to basal values during drug-free intervals, responders in the SF68 group maintained improvement throughout the study. In conclusion, SF68 is at least as useful as lactulose for the chronic treatment of chronic hepatic encephalopathy; it has no adverse effects, and treatment can be interrupted for 2 weeks without losing the beneficial effects.


Asunto(s)
Enterococcus faecium/fisiología , Fármacos Gastrointestinales/uso terapéutico , Encefalopatía Hepática/terapia , Lactulosa/uso terapéutico , Cirrosis Hepática/terapia , Adulto , Anciano , Amoníaco/sangre , Relación Dosis-Respuesta a Droga , Método Doble Ciego , Potenciales Evocados Visuales/fisiología , Femenino , Encefalopatía Hepática/fisiopatología , Humanos , Cirrosis Hepática/fisiopatología , Masculino , Persona de Mediana Edad , Índice de Severidad de la Enfermedad , Factores de Tiempo
13.
Ital J Gastroenterol ; 26(4): 174-8, 1994 May.
Artículo en Inglés | MEDLINE | ID: mdl-7949260

RESUMEN

The short-term metabolic effects of a dietary supplementation of biscuits containing raw fibre and lactulose (Fiberlac, Bracco) on circadian glucose, insulin and amino acid concentrations were studied in 10 obese patients in a crossover comparison. The biscuits (3 at breakfast, 4 at lunch and 4 at evening meal; approximately 10 g total dietary fibre, 2 g raw fibre, 8.25 g lactulose) were randomly substituted for an equicaloric part of a diet containing 20-22 kcal per kg ideal body weight under strict medical surveillance. Blood glucose in response to meal, as well as mean concentration throughout the day was lower during fibre supplementation. Also mean insulin was halved, and the insulin response to meals was blunted by 100-250 pmol/L. The plasma amino acid response to meals was increased, possibly in relation to decreased insulinemia. The data show a remarkable metabolic effect of the preparation in obese patients, without any further dietary restriction. The clinical effects and compliance remain to be determined in long-term studies, and in other states of glucose-intolerance, e.g. liver cirrhosis.


Asunto(s)
Aminoácidos/sangre , Glucemia/análisis , Dieta Reductora , Fibras de la Dieta/administración & dosificación , Ingestión de Energía , Alimentos Fortificados , Insulina/sangre , Lactulosa/administración & dosificación , Obesidad/sangre , Obesidad/dietoterapia , Adulto , Anciano , Peso Corporal , Ritmo Circadiano , Estudios Cruzados , Ayuno , Femenino , Humanos , Masculino , Persona de Mediana Edad , Obesidad/fisiopatología , Proyectos Piloto
14.
Hepatogastroenterology ; 39(5): 443-6, 1992 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-1459529

RESUMEN

The effects of oral BCAA supplementation on fasting levels of prolactin and estradiol were retrospectively analyzed in frozen plasma samples of patients with cirrhosis and chronic hepatic encephalopathy, taking part in a 3-month randomized, double-blind trial. Twenty-five patients had received 0.24g of BCAA per kg body weight, 24 had received an equinitrogenous amount of casein, in addition to a diet providing 0.7-1.0 g/kg of protein. Thirty-eight were males, 11 post-menopausal women. Fasting prolactin did not show any change in the BCAA group, where mental state significantly improved. In the casein group plasma prolactin increased by nearly 50% during the 3-month period. Similarly, estradiol concentrations were unchanged during BCAA supplementation, and increased during casein treatment. The analysis of variance demonstrated significant differences between the 2 treatments. Liver function tests and nutritional parameters (albumin, transferrin, urinary creatinine) supported a superiority of BCAA over casein. These data suggest that the favorable effects of BCAA on mental state are not mediated by changes in cerebral neurotransmission, but are due mainly to maintained liver function, possibly related to improved nutrition.


Asunto(s)
Aminoácidos de Cadena Ramificada/uso terapéutico , Estradiol/sangre , Encefalopatía Hepática/tratamiento farmacológico , Cirrosis Hepática/complicaciones , Prolactina/efectos de los fármacos , Administración Oral , Adulto , Anciano , Aminoácidos de Cadena Ramificada/administración & dosificación , Caseínas/administración & dosificación , Enfermedad Crónica , Método Doble Ciego , Femenino , Encefalopatía Hepática/sangre , Encefalopatía Hepática/etiología , Humanos , Cirrosis Hepática/sangre , Masculino , Persona de Mediana Edad , Prolactina/sangre , Estudios Retrospectivos
15.
G Ital Chemioter ; 39(1-3): 11-5, 1992.
Artículo en Italiano | MEDLINE | ID: mdl-1365744

RESUMEN

The author's studied the adherence ability of Enterococcus faecium SF 68 compared to that of Enterococcus faecalis IM 11f, on various substrates: vascular catheters and cardiac valves of rabbit, immunodepressed rats and diabetic rats. The bacterial adherence test was calculated by the number of bacteria adhered for microscopic field enlarged to 2000. The data obtained by scanning electron microscope SEM (Cambridge Stereoscan 150 MK2) revealed a different adherence action of the two germs on the various substrates. All the adherence tests showed a higher and uniform adherence activity of E. faecalis compared to that of E. faecium.


Asunto(s)
Adhesión Bacteriana , Enterococcus faecalis/fisiología , Enterococcus faecium/fisiología , Animales , Microscopía Electrónica de Rastreo , Conejos , Ratas , Propiedades de Superficie
17.
J Hepatol ; 11(1): 92-101, 1990 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-2204661

RESUMEN

In a double blind randomized study, branched-chain amino acids and placebo (casein) were compared as a treatment for chronic hepatic encephalopathy in cirrhosis. After a 15-day run-in period with controlled diet (45-65 g protein), the patients were administered, in addition to their diet, branched-chain amino acids (0.24 g/kg, 30 patients) or an equinitrogenous amount of casein (34 patients). One patient on branched-chain amino acids and two on casein were lost to the study. After 3 months, the index of portal-systemic encephalopathy significantly improved in patients on active treatment (from 40 [S.D. 14]% to 21 [17]), but was not in subjects receiving casein (from 37 [13]% to 36 [12]). Two or more parameters of the index improved in 24 patients treated with amino acids (80%; confidence limits, 61-92%), and only in 12 receiving casein (35%; confidence limits, 20-54%; p less than 0.001). Patients who did not improve were given an alternative treatment for 3 more months. Casein-treated patients given branched-chain amino acids rapidly improved. The changes in neuropsychologic function were associated with an improvement in semiquantitative nitrogen balance, which became consistently positive in amino acid-treated subjects; there was also a mild improvement in nutritional parameters and in liver function tests. The supplementation of oral branched-chain amino acids to the diet is superior to casein as a treatment for providing adequate nitrogen supply and improving the mental state of cirrhotic patients with chronic encephalopathy.


Asunto(s)
Aminoácidos de Cadena Ramificada/uso terapéutico , Encefalopatía Hepática/tratamiento farmacológico , Adulto , Anciano , Glucemia/análisis , Caseínas/uso terapéutico , Enfermedad Crónica , Método Doble Ciego , Femenino , Glucagón/sangre , Encefalopatía Hepática/epidemiología , Encefalopatía Hepática/metabolismo , Humanos , Insulina/sangre , Cirrosis Hepática/metabolismo , Cirrosis Hepática/fisiopatología , Masculino , Persona de Mediana Edad , Estudios Multicéntricos como Asunto , Nitrógeno/metabolismo , Placebos , Ensayos Clínicos Controlados Aleatorios como Asunto , Hormonas Tiroideas/sangre
18.
Clin Physiol Biochem ; 8(2): 101-7, 1990.
Artículo en Inglés | MEDLINE | ID: mdl-2361352

RESUMEN

Liver cirrhosis is characterized by low plasma levels of branched chain amino acids (BCAA) and high concentrations of aromatic amino acids (AAA), and this imbalance has been implicated in the pathogenesis of hepatic encephalopathy by the synthesis of altered neurotransmitters. Contrasting results on intravenous or oral BCAA efficacy and metabolic impact have already been reported, but studies reported in the literature were never longer than a few weeks. After oral administration of BCAA and a standard diet to 28 cirrhotic patients for 1 year, no modifications in plasma concentrations of BCAA could be observed up to 3 months of therapy. Our data and an accurate analysis of the current literature lead us to propose the hypothesis that in the impaired nitrogen metabolism following cirrhosis there are neither single metabolic presentations nor many perturbations, but numerous 'subpopulations' of patients who present a homogeneous pattern of alterations that may distinguish them in terms of therapeutic approach.


Asunto(s)
Aminoácidos de Cadena Ramificada/uso terapéutico , Cirrosis Hepática/tratamiento farmacológico , Adulto , Anciano , Aminoácidos de Cadena Ramificada/sangre , Femenino , Estudios de Seguimiento , Alimentos Fortificados , Hemodinámica , Humanos , Cirrosis Hepática/sangre , Masculino , Persona de Mediana Edad , Nitrógeno/metabolismo
19.
G Ital Chemioter ; 36(1-3): 65-8, 1989.
Artículo en Italiano | MEDLINE | ID: mdl-2488915

RESUMEN

The normal intestinal flora is an important defence against various infectious agents. It also allows important metabolic stages in the host. The Authors studied the ability of Enterococcus faecium SF 68 to protect the mice (Swiss strain) from infection by Salmonella typhi and its role when used with penicillin in infection by Staphylococcus aureus. Our results showed that SF 68, determined a good protection against infection. Moreover the association E. faecium SF 68-antibiotic lowers the mortality rate in the infected mice compared with the control group.


Asunto(s)
Bacterias Grampositivas/fisiología , Salmonelosis Animal/prevención & control , Infecciones Estafilocócicas/terapia , Animales , Terapia Combinada , Intestinos/microbiología , Masculino , Ratones , Penicilinas/uso terapéutico , Infecciones Estafilocócicas/tratamiento farmacológico
20.
Life Sci ; 44(2): 131-5, 1989.
Artículo en Inglés | MEDLINE | ID: mdl-2915595

RESUMEN

A decrease of both hypothalamic and cortical CCK occurred in the brain of rats killed 8 hours after hepatic artery ligation following portocaval anastomosis. Brain CCK depletion was not reproduced by exogenously provoked hyperammonemia nor by insulin-induced hypoglycemia, thus suggesting a central mechanism for the derangement of the CCKergic system in the course of acute liver failure.


Asunto(s)
Encéfalo/metabolismo , Colecistoquinina/metabolismo , Hepatopatías/metabolismo , Amoníaco/sangre , Animales , Glucemia/metabolismo , Corteza Cerebral/metabolismo , Modelos Animales de Enfermedad , Hipotálamo/metabolismo , Masculino , Ratas , Ratas Endogámicas
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA